Conshohocken, PA – TJP, an independent agency specializing in value & patient access for life sciences, and strategy-led creative for consumer brands, today announced its acquisition of Evolution Consulting & Research, a premier life sciences market research organization.
The acquisition marks another major milestone in TJP’s strategic growth, establishing an integrated, end-to-end engine that encompasses Research, Strategy, Creative, Pull-Through, and Analytics. Following the earlier addition of FX2 Virtual—which incorporated Virtual Sales Professionals, Virtual Key Account Managers (vKAMs), reimbursement specialists, and omnichannel data analytics—the inclusion of Evolution Consulting & Research rounds out TJP’s platform, giving life sciences clients seamless continuity from upfront market research to field-level commercial execution.
“Bringing Evolution Consulting & Research into the TJP family fulfills our vision of offering a unified, end-to-end platform,” said Rino Mariconda, CEO of TJP and Operating Partner at Renovus Capital Partners. “We entered this year with foundational, strategy-led creative and access capabilities. By integrating FX2 Virtual’s commercial deployment infrastructure and now Evolution’s high-caliber, best-in-class market research expertise, we have bridged the gap from early clinical and commercial insights to active market pull-through. Our clients can now partner with a single organization to uncover vital market insights, formulate strategy, craft compelling narratives, and execute field pull-through with measurable impact.”
“Joining forces with TJP and Renovus Capital Partners represents an exciting new chapter for Evolution and our clients,” said Mike Heasley, Partner of Evolution Consulting & Research. “Market research delivers the greatest value when insights directly shape strategy, creative execution, and downstream commercial pull-through. By aligning our deep market research capabilities with TJP’s access strategy, creative excellence, and virtual field execution teams, we are creating an agency capable of supporting life sciences brands across every stage of their lifecycle.”
The combination establishes a cohesive commercial continuum for pharmaceutical and biotechnology partners navigating increasingly complex market access and pricing environments. By harmonizing primary research, access strategy, creative campaigns, virtual sales execution, and advanced analytics, TJP delivers an integrated model designed to optimize brand performance, maximize ROI, and accelerate patient access to life-changing therapies.